Molecular-genetic aspects of neurofibromatosis;Moleculair-genetische aspecten van neurofibromatosis

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 13, 1997, Pages 620-623

  Hulsebos, T J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MERLIN; NEUROFIBROMIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CHROMOSOME 17; CHROMOSOME 22; GENE MUTATION; HUMAN; MOLECULAR GENETICS; NEUROFIBROMATOSIS; TUMOR SUPPRESSOR GENE;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 22; GENES, NEUROFIBROMATOSIS 1; GENES, NEUROFIBROMATOSIS 2; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; MICE; NEOPLASM PROTEINS; NEUROFIBROMATOSES; NEUROFIBROMIN 1; NEUROFIBROMIN 2; PROTEINS;

EID: 0030975589     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Fleury P. Neurofibromatosis; genetische en klinische aspecten. Ned Tijdschr Geneeskd 1989;133:2279-83.
2. Huson SM, Hughes RAC. The neurofibromatoses: a pathogenetic and clinical overview. London: Chapman and Hall, 1994.
3. Overweg-Plandsoen WCG, Weersink RGM, Sillevis Smitt JH, Fleury P, Asperen CJ van. Neurofibromatosis type 1: een overzicht van 196 patiënten. Ned Tijdschr Geneeskd 1997;141:624-9.
4. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-92.
5. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990;249: 181-6.
6. Li Y, O'Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, et al. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 1995;25:9-18.
7. Knudson jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
8. Bijlsma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos TJM. Molecular characterization of chromosome 22 deletions in schwannomas. Genes Chromosomes Cancer 1992;5:201-5.
9. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72: 791-800.
10. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993;363:515-21.
11. Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, et al. Analysis of mutations in the SCH gene in schwannomas. Genes Chromosomes Cancer 1994;11:7-14.
12. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, Drunen E van, et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994;54:1022-9.
13. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995;11:90-2.
14. Sawada S, Florell S, Purandere SM, Ota M, Stephens K, Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 1996;14:110-2.
15. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994;7:353-61.
16. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994;8:1019-29.